The rapid emergence of microbial resistance makes the development of novel antibiotic agents urgent. Antimicrobial peptides, characterized by a positive charge and amphipathic structure, are considered promising candidates, as they display high therapeutic indices in vitro (16) . One putative active domain of histatin 5 (Dh5: residues 11 to 24) was used as scaffold for the design of peptides Dhvar4 (increased amphipathicity) and Dhvar5 (reduced amphipathicity) with improved potency in vitro and improved resistance to proteolytic degradation (14, 5, 10, 4) . P-113 (residues 4 to 15 of histatin 5) is active against several clinically important pathogens in vitro and in vivo in animals (7, 9, 2, 3) .
In this study we examined the effect of dimerization of Dh5, Dhvar4, Dhvar5, and P-113 on the antimicrobial potency in vitro and in mice with Staphylococcus aureus infections. The rationale behind using homodimers of antimicrobial peptides is that multiple peptides line up together in a dose-dependent fashion so that dimerization would lead to an increase in reaction rates and thus to a significant potentiation (11) . Peptides and their homodimers were synthesized as described previously (12, 15) and are listed in Table 1 . S. aureus ATCC 25923 was obtained from the American Type Culture Collection (Rockville, MD). S. aureus strain 2141 (multidrug-resistant S. aureus [MRSA] ) is a multidrug-resistant clinical isolate (1) . In the in vitro assay, 1 ϫ 10 6 /ml S. aureus organisms in phosphate buffer supplemented with 1% (wt/vol) tryptic soybean broth (Difco, Becton Dickinson Microbiology Systems, Sparks, MD) were exposed to various amounts of peptides for 2 h at 37°C, and the number of viable microorganisms was assessed microbiologically using DST plates as described by Welling et al. (18) . Data are expressed as 50% lethal concentrations (LC 50 ), i.e., in vitro as the concentration required reducing the viable bacteria by 50% compared to incubations without peptide. Histatin 5, Dh5, P-113, Dhvar4, and Dhvar5 killed both S. aureus and MRSA. Histatin 5 and Dhvar4 were the most potent peptides ( Table 2 ). The dimers of Dh5, a Mean hydrophobic moments, a measure for amphipathicity, calculated assuming ␣-helical conformation of the peptides. b Mean hydrophobicity. For the dimers, the hydrophobicity of the lysine-amide spacer was considered similar to that of glutamine (Ϫ0.69) or asparagine (Ϫ0.64), which resulted in values that did not differ significantly from those of the respective monomers. Dhvar4, and Dhvar5 were 4, 11, and 128 times as potent as the respective monomers against S. aureus and 14, 8, and 43 times as potent against MRSA. For P-113, dimerization led to a decrease in bactericidal potency.
Binding of equal amounts of 99m Tc-labeled peptides to bacteria was assessed at 4°C as described previously (18) . In short, labeled peptide was incubated with 2 ϫ 10 7 viable bacteria for 1 h, and the radioactivity bound to the bacterial pellet was determined. Data are expressed as the percentage of total added 99m Tc activity/2 ϫ 10 7 CFU. With exception of Dhvar5, the dimers of all peptides showed significantly (P Ͻ 0.01) higher binding than their respective monomers (Fig. 1) . Notably, for this peptide the effect of dimerization on the bactericidal effect was the most pronounced. In the in vivo studies, performed in compliance with the Dutch laws related to the conduct of animal experiments, pathogen-free male Swiss mice (22 to 30 g; Broekman Institute, Someren, The Netherlands) were infected with 0.1 ml saline containing 0.5 to 2.0 ϫ 10 7 CFU (18). After 18 h, animals were given intravenous injections of various amounts of peptide. The animals were kept for another 24 h and sacrificed, and the number of viable bacteria 
a Concentration required to reduce viable counts by 50% compared to incubations without peptide (in vitro) (M) or to reduce viable counts by 50% compared to untreated mice (in vivo) (mol/g of infected tissue). In vitro results are means from at least three sets of independent experiments; in vivo results are means from at least three independent animals per peptide concentration. Table 2 ). The high in vivo activity is surprising. In a pilot experiment in vitro using phosphatebuffered saline instead of a low-phosphate buffer to better simulate physiological conditions, we found that the activities of all peptides were virtually abolished at higher ionic strengths. Furthermore, in vivo these bacteria exist as multicellular complexes (biofilms), in which form they are far more resistant to antimicrobial peptides than the cultured monocellular planktonic bacteria used in the in vitro assays (8) . A possible explanation is that the activity of this kind of peptide in vivo is not a reflection of their cytolytic activity expressed in vitro but the result of their immunomodulatory properties (17, 13, 6) . Apparently, these are not influenced by dimerization. Scintigraphic imaging after intravenous injection of mice with technetium-99m-radiolabeled peptides (2 to 5 MBq) revealed that the peptides were rapidly removed (biological halflife between 9 to 39 min) from the circulation (19, 18) . Most of the radioactivity accumulated initially in the kidneys, after which it collected in the urinary bladder (Table 3) . It was observed at later intervals that radioactivity that had accumulated in the liver and spleen also rapidly decreased (data not shown). Only a small amount (0.5 to 0.9% of the injected dose) accumulated at the infected thigh muscles.
The accumulation of peptides varied, with ratios of accumulation in infected thigh muscle (target [T] ) to accumulation in the contralateral noninfected thigh muscle (nontarget [NT] ) between 1.6 and 4.4 for mice infected with S. aureus (Fig. 2) . The highest T/NT ratios were calculated for monomeric (3.5 Ϯ 0.4) and dimeric (4.4 Ϯ 0.4) peptides of Dh5. For mice infected with MRSA, T/NT ratios for all peptides ranged between 1.8 and 2.4 (Fig. 2) . We do not have a conclusive explanation for the differences in T/NT ratios observed for radiolabeled Dh5 and its dimer between S. aureus and MRSA.
Apparently, there is no clear correlation between bacterial binding, ionic strength sensitivity, and bactericidal activity in vitro on the one hand and biodistribution data, clearance kinetics, and bactericidal activity in vivo on the other. It is evident that extrapolation of in vitro findings to the observations in animals is extremely difficult. Peptide properties determined in vitro, such as pore-forming and membrane-disrupting properties, secondary structure, and state of aggregation, may be different in vivo. The presence of many potentially synergistic compounds and an active immune system in live animals is another complicating factor. Considering that potentially antimicrobial peptides act in vivo through other molecular mechanisms than in vitro, we think that a critical reappraisal of the predictive value of data obtained in vitro for actual activity in vivo may be imperative. Despite the uncertainty as to how these peptides exert their potent antimicrobial activity in vivo, our data clearly show that they may be considered as promising new therapeutics to fight infections with resistant bacteria.
FIG. 2. Accumulation of
99m Tc-labeled histatin peptides (open bars, histatin 5; vertically striped bars, Dh5; diagonally striped bars, dimeric Dh5; black bars, Dhvar4; horizontally striped bars, dimeric Dhvar4; gray bars, Dhvar5; stippled bars, dimeric Dhvar5) in thigh muscles of mice infected with S. aureus (top) or MRSA (bottom). T/NT ratios were determined at the indicated intervals as described in the text.
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